Lowering triglycerides methods
Pro Research Analysisby 
Searched over 200M research papers
Lifestyle Changes for Lowering Triglycerides
Lifestyle modifications are a primary and effective approach to lowering triglyceride levels. Weight loss is particularly impactful; losing 5–10% of body weight can reduce triglycerides by 20–30%. Dietary changes such as reducing total fat intake, eliminating trans fats, increasing omega-3 polyunsaturated fatty acids (PUFAs), replacing saturated fats with monounsaturated fats and PUFAs, and substituting refined sugars with fiber-rich foods like fruits, vegetables, and whole grains are all recommended. Regular physical activity can further lower triglycerides by about 20%. Altogether, these lifestyle changes can reduce triglyceride levels by up to 50% and improve overall cardiometabolic health .
Pharmacological Methods for Triglyceride Reduction
Several medications are available for lowering triglycerides. Traditional therapies include fibrates, niacin, and omega-3 fatty acids, which are partially effective. Newer agents under development target specific enzymes and pathways involved in triglyceride metabolism, such as PPAR agonists, MTTP inhibitors, DGAT-1 inhibitors, incretin mimetics, and antisense oligonucleotides targeting apolipoproteins. Some therapies, like CETP inhibitors and PCSK9 monoclonal antibodies, have shown variable results. The clinical benefit of these newer drugs, especially regarding cardiovascular outcomes, is still being studied Sahebkar2014Pirillo2023.
Omega-3 Fatty Acids and Triglyceride Lowering
Omega-3 fatty acids, especially at prescription doses (4 g/day), are effective in reducing triglycerides by at least 30%. Both EPA+DHA and EPA-only formulations are effective, with EPA-only not increasing LDL cholesterol. High-dose EPA has shown a 25% reduction in major cardiovascular events in high-risk patients, suggesting benefits beyond triglyceride lowering. Omega-3s work by reducing hepatic VLDL production and may also inhibit intestinal triglyceride absorption through N-acyl taurines Marston2019Bornfeldt2021Skulas-Ray2019.
GLP-1 Receptor Agonists for Hypertriglyceridemia
GLP-1 receptor agonists, originally developed for type 2 diabetes, have been shown to significantly lower triglycerides, especially in patients with obesity, diabetes, non-alcoholic fatty liver disease, and polycystic ovary syndrome. Semaglutide and liraglutide are particularly effective, with semaglutide providing the greatest reduction. These agents also offer benefits in glycemic control and weight loss, making them valuable for patients with metabolic syndrome .
Rapid Triglyceride Lowering in Acute Pancreatitis
In cases of hypertriglyceridemic acute pancreatitis, rapid reduction of triglyceride levels is important to lower the risk of complications. Treatments such as insulin and a combination of low molecular weight heparin with bezafibrate have been shown to reduce the incidence of infectious pancreatic necrosis and persistent organ failure compared to conservative management .
Triglyceride Lowering and Cardiovascular Risk
Lowering triglycerides is associated with a reduction in cardiovascular events and cardiovascular-specific mortality, especially in patients with diabetes. However, the benefit is most pronounced when triglyceride lowering is accompanied by a reduction in atherogenic lipoproteins, such as apolipoprotein B. Not all triglyceride-lowering drugs reduce cardiovascular risk unless they also lower these atherogenic particles Marston2019Yang2023Pirillo2023.
Novel and Emerging Therapies
New therapies targeting apolipoprotein C-III and angiopoietin-like protein 3 are being developed to further lower triglycerides. These may offer additional benefits, but their impact on cardiovascular outcomes is still under investigation Sahebkar2014Pirillo2023.
Conclusion
Lowering triglycerides can be achieved through a combination of lifestyle changes, established medications, and newer therapies. Lifestyle interventions remain the cornerstone, while pharmacological options are available for those needing additional reduction. Omega-3 fatty acids and GLP-1 receptor agonists are particularly effective, especially in patients with metabolic conditions. Rapid lowering is crucial in acute pancreatitis. The greatest cardiovascular benefit is seen when triglyceride reduction is accompanied by a decrease in atherogenic lipoproteins. Ongoing research will clarify the role of emerging therapies in optimizing triglyceride management and reducing cardiovascular risk.
Sources and full results
Most relevant research papers on this topic